Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430827
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-04-15
Brief Title:
Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma
Sponsor:
Ba Yi
Organization:
Peking Union Medical College Hospital
Organization Data
Organization:
Peking Union Medical College Hospital
Class:
OTHER
Study ID:
CSPC-DNY-BTC-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ba Yi
Lead Sponsor Class:
OTHER
Responsible Party:
Ba Yi
Responsible Party Title:
Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Peking Union Medical College Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| CSPC Ouyi Pharmaceutical Co Ltd | INDUSTRY |